O'Keefe Stevens Advisory’s Abbott ABT Stock Holding History

O'Keefe Stevens Advisory’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,615	Closed	-$202K	–	77
2025 Q4	$202K	Hold	1,615	–	–	0.05%	66
2025 Q3	$216K	Hold	1,615	–	–	0.06%	63
2025 Q2	$220K	Hold	1,615	–	–	0.06%	65
2025 Q1	$214K	Buy	+1,615	New	+$206K	0.07%	67

Other funds holding ABT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

O'Keefe Stevens Advisory's ABT Position: Q1 2026 in Review

O'Keefe Stevens Advisory sold out of Abbott (ABT) in Q1 2026, closing a stake of 1,615 shares — an estimated $202K sold.

O'Keefe Stevens Advisory first reported a position in ABT in Q1 2025 and held it in 4 quarters. The position peaked at $220K in Q2 2025. 3,090 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

O'Keefe Stevens Advisory reported no remaining Abbott position as of Q1 2026 after selling out during the quarter.
O'Keefe Stevens Advisory sold 1,615 Abbott shares in Q1 2026, an estimated $202K.
O'Keefe Stevens Advisory first reported a position in Abbott in Q1 2025 and held it in 4 quarters.
O'Keefe Stevens Advisory's Abbott position peaked at $220K in Q2 2025.
3,090 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on O'Keefe Stevens Advisory's 13F filing for Q1 2026, filed 7 Apr 2026.